Table 3 Treatment response in different populations
ITT population (N = 45) | Evaluable population (N = 43) | Estrogen receptor positive (N = 26) | Her-2 positive (N = 5) | |
|---|---|---|---|---|
Tumor response | ||||
CR, n (%) | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) |
PR, n (%) | 18 (40.0 %) | 18 (41.9 %) | 12 (46.2 %) | 1 (20.0 %) |
SD, n (%) | 18 (40.0 %) | 18 (41.9 %) | 11 (42.3 %) | 3 (60.0 %) |
PD, n (%) | 7 (15.6 %) | 7 (16.3 %) | 2 (7.7 %) | 1 (20.0 %) |
NE, n (%) | 2 (4.4 %) | 0 (0.0 %) | 1 (3.8 %) | 0 (0.0 %) |
Disease control rate | ||||
CR + PR + SD, n (%) | 36 (80.0 %) | 36 (83.7 %) | 23 (88.5 %) | 4 (80 %) |
Objective response rate | ||||
CR + PR, n (%) | 18 (40.0 %) | 18 (41.9 %) | 12 (46.2 %) | 1 (20.0 %) |